Document is current
Any future updates will be listed below
-
Authors
Mewaldt, Christian
Crawford, Emily
Cluett, Jennifer
Arvanitis, Lorenzo V.
Kentoffio, Katie
Secemsky, Eric A.
Krawisz, Anna K.
- License Information
-
More Information
Article History
Accepted: 27 October 2024
First Online: 16 November 2024
Declarations
:
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: Jennifer Cluett reports being a Co-investigator for the following: NIH/NHLBI R56L153191, R01HL53191; AHA Health Equity Research Network Grant; NIH/NIMHD R01MD016068; and NIH/NHLBI R01HL158622; and President, American Heart Association Greater Boston Board of Directors. Eric Secemsky reports grants or contracts from BD, Laminate, CSI, Philips, Boston Scientific, Medtronic, Cook Medical, SCAI, and the Food and Drug Administration. He also reports consulting fees from Boston Scientific, BD, Cook, Cagent, Conavi, Abbott, Corids, InfraRex, Medtronic, Philips, RapidAI, Shockwave, VentureMed, and Veryan. He also reports serving on the advisory board, speakers bureau, and as a consultant for Medtronic. Anna Krawisz reports serving as a speaker for Medtronic; honorarium for giving grand rounds about hypertension; and PI for the BaxHTN clinical trial for AstraZeneca, and Co-PI for the Spyral affirm trial for Medtronic. The other authors declare that they have no conflict of interest.
